Santhera expands Biomedica pact to distribute AGAMREE in Central Asia, Caucasus

(AWP Alliance News) - Santhera Pharmaceuticals expanded its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending coverage to Central Asia and the Caucasus. The deal adds Georgia, Kazakhstan, Belarus, Azerbaijan, and Uzbekistan for treatment of Duchenne muscular dystrophy in patients aged two and older.

Biomedica will handle distribution in the new markets. Santhera will continue to receive a percentage of net sales under the original terms.

The company estimated about 2,000 DMD patients live across the added countries.

http://www.globenewswire.com/newsroom/news.html?d=1001212409

Disclaimer: This news brief was created using generative artificial intelligence. Santhera Pharmaceuticals Holding AG published the original content used to generate this news brief via GlobeNewswire on July 13, 2026, and is solely responsible for the information contained therein.